Literature DB >> 12350160

Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp.

Philip G Williams1, Wesley Y Yoshida, Richard E Moore, Valerie J Paul.   

Abstract

The acyclic peptide tasiamide (1) has been isolated from the marine cyanobacterium Symploca sp. The planar structure and absolute stereochemistry of the peptide were deduced by 2D NMR techniques and chiral HPLC. Tasiamide (1) was cytotoxic against KB and LoVo cells with IC(50) values of 0.48 and 3.47 microg/mL, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12350160     DOI: 10.1021/np020184q

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  12 in total

Review 1.  Chemical genetic approaches to probing cell death.

Authors:  Nidhi M Gangadhar; Brent R Stockwell
Journal:  Curr Opin Chem Biol       Date:  2006-12-14       Impact factor: 8.822

2.  Grassystatins D-F, Potent Aspartic Protease Inhibitors from Marine Cyanobacteria as Potential Antimetastatic Agents Targeting Invasive Breast Cancer.

Authors:  Fatma H Al-Awadhi; Brian K Law; Valerie J Paul; Hendrik Luesch
Journal:  J Nat Prod       Date:  2017-10-31       Impact factor: 4.050

Review 3.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

4.  Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.

Authors:  Jason C Kwan; Erika A Eksioglu; Chen Liu; Valerie J Paul; Hendrik Luesch
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

Review 5.  Marine Peptides: Bioactivities and Applications.

Authors:  Randy Chi Fai Cheung; Tzi Bun Ng; Jack Ho Wong
Journal:  Mar Drugs       Date:  2015-06-29       Impact factor: 5.118

6.  Design, synthesis and biological evaluation of tasiamide analogues as tumor inhibitors.

Authors:  Wei Zhang; Tiantian Sun; Zhenhua Ma; Yingxia Li
Journal:  Mar Drugs       Date:  2014-04-22       Impact factor: 5.118

Review 7.  Nonribosomal Peptides from Marine Microbes and Their Antimicrobial and Anticancer Potential.

Authors:  Shivankar Agrawal; Debabrata Acharya; Alok Adholeya; Colin J Barrow; Sunil K Deshmukh
Journal:  Front Pharmacol       Date:  2017-11-21       Impact factor: 5.810

Review 8.  Marine cyanobacteria compounds with anticancer properties: a review on the implication of apoptosis.

Authors:  Margarida Costa; João Costa-Rodrigues; Maria Helena Fernandes; Piedade Barros; Vitor Vasconcelos; Rosário Martins
Journal:  Mar Drugs       Date:  2012-09-28       Impact factor: 6.085

9.  Lipopeptides from the tropical marine cyanobacterium Symploca sp.

Authors:  Emily Mevers; F P Jake Haeckl; Paul D Boudreau; Tara Byrum; Pieter C Dorrestein; Frederick A Valeriote; William H Gerwick
Journal:  J Nat Prod       Date:  2014-03-03       Impact factor: 4.050

Review 10.  Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides.

Authors:  Hee Kyoung Kang; Moon-Chang Choi; Chang Ho Seo; Yoonkyung Park
Journal:  Int J Mol Sci       Date:  2018-03-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.